Affinity DataKi: 14nMAssay Description:Competitive inhibition of thymidylate synthase purified from methotrexate-resistant Lactobacillus casei using 2'-deoxy[5-3H]uridine 5'-phosphate by r...More data for this Ligand-Target Pair
Affinity DataKi: 29nMAssay Description:Competitive inhibition of thymidylate synthase purified from methotrexate-resistant Lactobacillus casei using 2'-deoxy[5-3H]uridine 5'-phosphate by r...More data for this Ligand-Target Pair
Affinity DataKi: 39nMAssay Description:Competitive inhibition of thymidylate synthase purified from methotrexate-resistant Lactobacillus casei using 2'-deoxy[5-3H]uridine 5'-phosphate by r...More data for this Ligand-Target Pair
Affinity DataKi: 40nMAssay Description:Competitive inhibition of thymidylate synthase purified from methotrexate-resistant Lactobacillus casei using 2'-deoxy[5-3H]uridine 5'-phosphate by r...More data for this Ligand-Target Pair
Affinity DataKi: 190nMAssay Description:Competitive inhibition of thymidylate synthase purified from methotrexate-resistant Lactobacillus casei using 2'-deoxy[5-3H]uridine 5'-phosphate by r...More data for this Ligand-Target Pair
Affinity DataKi: 500nMAssay Description:Inactivation of thymidylate synthetase measured asKi at 6.8 pH 30 degrees centigrade tempMore data for this Ligand-Target Pair
Affinity DataKi: 500nMAssay Description:Inactivation of thymidylate synthetase measured asKi at 6.8 pH 30 degrees centigrade tempMore data for this Ligand-Target Pair
Affinity DataKi: 550nMAssay Description:Competitive inhibition of thymidylate synthase purified from methotrexate-resistant Lactobacillus casei using 2'-deoxy[5-3H]uridine 5'-phosphate by r...More data for this Ligand-Target Pair
Affinity DataKi: 1.40E+3nMAssay Description:Competitive inhibition of thymidylate synthase purified from methotrexate-resistant Lactobacillus casei using 2'-deoxy[5-3H]uridine 5'-phosphate by r...More data for this Ligand-Target Pair
Affinity DataKi: 1.60E+3nMAssay Description:Competitive inhibition of thymidylate synthase purified from methotrexate-resistant Lactobacillus casei using 2'-deoxy[5-3H]uridine 5'-phosphate by r...More data for this Ligand-Target Pair
Affinity DataKi: 2.00E+3nMAssay Description:Inactivation of thymidylate synthetase measured asKi at 6.8 pH 30 degrees centigrade tempMore data for this Ligand-Target Pair
Affinity DataKi: 2.80E+3nMAssay Description:Competitive inhibition of Lactobacillus casei thymidylate synthetase using dTMP as substrate assessed as release of water after 15 mins by double rec...More data for this Ligand-Target Pair
Affinity DataKi: 4.00E+3nMAssay Description:Inactivation of thymidylate synthetase measured as Ki at 6.8 pH 30 degrees centigrade tempMore data for this Ligand-Target Pair
Affinity DataKi: 1.00E+5nMAssay Description:Competitive inhibition of Lactobacillus casei thymidylate synthetase using 2'-deoxy[5-3H]uridine-5'-phosphate as substrate assessed as release of wat...More data for this Ligand-Target Pair
Affinity DataKi: 1.50E+5nMAssay Description:Competitive inhibition of Lactobacillus casei thymidylate synthetase using 2'-deoxy[5-3H]uridine-5'-phosphate as substrate assessed as release of wat...More data for this Ligand-Target Pair
Affinity DataIC50: >5nMAssay Description:Inhibition of human umbilical vein endothelial cell adhesion to fibronectinMore data for this Ligand-Target Pair
Affinity DataIC50: >5nMAssay Description:Inhibition of human umbilical vein endothelial cell adhesion to fibrinogenMore data for this Ligand-Target Pair
Affinity DataIC50: >5nMAssay Description:Inhibition of human umbilical vein endothelial cell adhesion to vitronectinMore data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of protein kinase CMore data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 29nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 47nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 63nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 105nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 140nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 240nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 260nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:Inhibition of protein kinase CMore data for this Ligand-Target Pair
TargetOxoeicosanoid receptor 1(Homo sapiens (Human))
Florida Institute Of Technology
Curated by ChEMBL
Florida Institute Of Technology
Curated by ChEMBL
Affinity DataIC50: 400nMAssay Description:Antagonist activity at OXE receptor in human neutrophils assessed as 5-oxo-ETE-induced Ca2+ mobilization incubated for 2 mins prior to 5-oxo-ETE addi...More data for this Ligand-Target Pair
Affinity DataIC50: 500nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 500nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 680nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 700nMAssay Description:Inhibition of protein kinase CMore data for this Ligand-Target Pair
Affinity DataIC50: 780nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 800nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 880nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
TargetOxoeicosanoid receptor 1(Homo sapiens (Human))
Florida Institute Of Technology
Curated by ChEMBL
Florida Institute Of Technology
Curated by ChEMBL
Affinity DataIC50: 1.17E+3nMAssay Description:Antagonist activity at OXE receptor in human neutrophils assessed as 5-oxo-ETE-induced Ca2+ mobilization incubated for 2 mins prior to 5-oxo-ETE addi...More data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
TargetOxoeicosanoid receptor 1(Homo sapiens (Human))
Florida Institute Of Technology
Curated by ChEMBL
Florida Institute Of Technology
Curated by ChEMBL
Affinity DataIC50: 1.55E+3nMAssay Description:Antagonist activity at OXE receptor in human neutrophils assessed as 5-oxo-ETE-induced Ca2+ mobilization incubated for 2 mins prior to 5-oxo-ETE addi...More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light .More data for this Ligand-Target Pair